Phase II Dose Ranging Study of Artesunate
NCT00459615
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
FED
Sponsor class
Conditions
Falciparum Malaria
Uncomplicated Malaria
Interventions
DRUG:
Artesunate for Injection
Sponsor
U.S. Army Office of the Surgeon General
Collaborators
[object Object]
[object Object]